المؤلفون: Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Plieskatt JL; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Soulama BI; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Naghizadeh M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Barry A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Yaro JBB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ezinmegnon S; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Henry N; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ofori EA; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Adu B; Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana., Singh SK; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Konkobo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Lövgren Bengtsson K; Novavax AB, Uppsala, Sweden., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Carnrot C; Novavax AB, Uppsala, Sweden., Reimer JM; Novavax AB, Uppsala, Sweden., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Tienta M; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Ouedraogo IN; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Sagara I; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Theisen M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 Apr 01; Vol. 134 (7). Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Clinical Trial, Phase I; Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Malaria Vaccines* , Malaria* , Malaria, Falciparum*, Adult ; Humans ; Plasmodium falciparum ; Protozoan Proteins ; Adjuvants, Immunologic ; Antigens, Protozoan ; Aluminum Hydroxide ; Antibodies, Protozoan

المؤلفون: Moreno M; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Barry A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Gmeiner M; Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands., Yaro JB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Sermé SS; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Byrne I; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Ramjith J; Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands., Ouedraogo A; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Soulama I; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Grignard L; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Soremekun S; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Koele S; Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands., Ter Heine R; Pharmacy, Radboudumc, Nijmegen, The Netherlands., Ouedraogo AZ; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Sawadogo J; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Sanogo E; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Ouedraogo IN; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Hien D; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Sirima SB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso., Bradley J; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Bousema T; Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands., Drakeley C; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK., Tiono AB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso a.tiono@gras.bf.

المصدر: BMJ open [BMJ Open] 2024 Mar 12; Vol. 14 (3), pp. e081682. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Clinical Trial Protocol; Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Antimalarials*/therapeutic use , Malaria*/epidemiology , Malaria*/prevention & control , Malaria*/drug therapy, Child, Preschool ; Humans ; Infant ; Burkina Faso/epidemiology ; Chemoprevention/methods ; Drug Combinations ; Randomized Controlled Trials as Topic ; Seasons ; Child

المؤلفون: Ouédraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Palacpac NMQ; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Japan., Houard S; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany., Nebie I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Sawadogo J; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Berges GD; Hôpital Protestant Schiphra, Ouagadougou, Burkina Faso., Soulama I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Hien D; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ouedraogo AZ; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Konaté AT; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Kouanda S; Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso., Myoui A; Medical Center for Translational Research, Osaka University Hospital, Suita, Japan., Ezoe S; Medical Center for Translational Research, Osaka University Hospital, Suita, Japan.; Department of Space Infection Control, Graduate School of Medicine, Division of Health Sciences, Osaka University, Osaka, Japan., Ishii KJ; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Suita, Japan.; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Sato T; Research and Development Division, Nobelpharma Co., Ltd., Tokyo, Japan., D'Alessio F; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany., Leroy O; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany., Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Cousens S; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine (LSHTM), London, United Kingdom., Horii T; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Japan., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.

المصدر: Frontiers in immunology [Front Immunol] 2023 Oct 16; Vol. 14, pp. 1267372. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023).

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Malaria Vaccines* , Malaria, Falciparum*/prevention & control , Malaria*/prevention & control, Male ; Humans ; Adult ; Child ; Infant ; Child, Preschool ; Young Adult ; Middle Aged ; Double-Blind Method ; Peptides

المؤلفون: Djimde M; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali., Kayentao K; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali., Tshiongo JK; Department of Tropical Medicine, University of Kinshasa (UNIKIN), Kinshasa, Democratic Republic of the Congo., Fofana B; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali., Arama C; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ouedraogo JB; Institut des Sciences et des Techniques Bobo Dioulasso (INSTech-Bobo), Burkina Faso., Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale (CNFRSR), Mafinrinha, Guinea., Sagara I; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali., Dicko A; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali., Mens PF; Amsterdam University Medical Centre, Academic Medical Centre at the University of Amsterdam (AMC), Amsterdam, The Netherlands., Schallig HD; Amsterdam University Medical Centre, Academic Medical Centre at the University of Amsterdam (AMC), Amsterdam, The Netherlands., Djimde A; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.

المصدر: Journal of infection in developing countries [J Infect Dev Ctries] 2023 Sep 30; Vol. 17 (9), pp. 1337-1345. Date of Electronic Publication: 2023 Sep 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet ISSN: 1972-2680 (Electronic) Linking ISSN: 19722680 NLM ISO Abbreviation: J Infect Dev Ctries Subsets: MEDLINE

مواضيع طبية MeSH: Antimalarials*/therapeutic use , Malaria, Falciparum*/drug therapy , Artemisinins*/therapeutic use , Malaria*/drug therapy , Neutropenia*/chemically induced, Humans ; Artesunate/therapeutic use ; Neutrophils ; Parasitemia/drug therapy ; Prospective Studies ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Amodiaquine/therapeutic use ; Drug Combinations ; Africa ; Plasmodium falciparum ; Ethanolamines/therapeutic use

المؤلفون: Tiono AB; Groupe de Recherche Action en Santé, Ouagadougou (GRAS), Ouagadougou, Burkina Faso.; Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Ouagadougou, Burkina Faso., Palacpac NMQ; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan., Bougouma EC; Groupe de Recherche Action en Santé, Ouagadougou (GRAS), Ouagadougou, Burkina Faso., Nebie I; Groupe de Recherche Action en Santé, Ouagadougou (GRAS), Ouagadougou, Burkina Faso., Ouédraogo A; Groupe de Recherche Action en Santé, Ouagadougou (GRAS), Ouagadougou, Burkina Faso., Houard S; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany., Arisue N; Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan., D'Alessio F; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany., Horii T; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan., Sirima SB; Groupe de Recherche Action en Santé, Ouagadougou (GRAS), Ouagadougou, Burkina Faso.

المصدر: Frontiers in immunology [Front Immunol] 2023 Mar 10; Vol. 14, pp. 1119820. Date of Electronic Publication: 2023 Mar 10 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Malaria Vaccines* , Malaria, Falciparum*/prevention & control , Malaria*/prevention & control, Humans ; Child ; Plasmodium falciparum ; Antigens, Protozoan ; Vaccination/adverse effects ; Immunoglobulin G ; Immunity

المؤلفون: Tiono AB; Groupe de Recherche Action en Santé (GRAS), 06 BP, 1028, Ouagadougou, Burkina Faso., Konaté AT; Groupe de Recherche Action en Santé (GRAS), 06 BP, 1028, Ouagadougou, Burkina Faso., Kargougou D; Centre National de Recherche et de Formation sur le Paludisme (CNRFP), 01 BP, 2208, Ouagadougou, Burkina Faso., Diarra A; Groupe de Recherche Action en Santé (GRAS), 06 BP, 1028, Ouagadougou, Burkina Faso., Ouedraogo IN; Groupe de Recherche Action en Santé (GRAS), 06 BP, 1028, Ouagadougou, Burkina Faso., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), 06 BP, 1028, Ouagadougou, Burkina Faso., Pagnoni F; The Barcelona Institute for Global Health, Rosselló, 132, 7è08036, Barcelona, Spain., Modiano D; University 'La Sapienza' of Roma, Roma, Italy., Sirima SB; Groupe de Recherche Action en Santé (GRAS), 06 BP, 1028, Ouagadougou, Burkina Faso. s.sirima@gras.bf.

المصدر: Malaria journal [Malar J] 2023 Jan 06; Vol. 22 (1), pp. 6. Date of Electronic Publication: 2023 Jan 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE

مواضيع طبية MeSH: Malaria*/epidemiology , Hypoglycemia* , Respiratory Distress Syndrome* , Malaria, Falciparum*/epidemiology, Child ; Humans ; Infant ; Adult ; Burkina Faso/epidemiology ; Coma ; Hemoglobinuria ; Hospitals

المؤلفون: Richie TL; Sanaria Inc, Rockville, MD, USA., Church LWP; Sanaria Inc, Rockville, MD, USA., Murshedkar T; Sanaria Inc, Rockville, MD, USA., Billingsley PF; Sanaria Inc, Rockville, MD, USA., James ER; Sanaria Inc, Rockville, MD, USA., Chen MC; Sanaria Inc, Rockville, MD, USA., Abebe Y; Sanaria Inc, Rockville, MD, USA., Natasha Kc; Sanaria Inc, Rockville, MD, USA., Chakravarty S; Sanaria Inc, Rockville, MD, USA., Dolberg D; Sanaria Inc, Rockville, MD, USA., Healy SA; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Diawara H; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Bamako, Mali., Sissoko MS; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Bamako, Mali., Sagara I; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Bamako, Mali., Cook DM; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Epstein JE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Mordmüller B; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany., Kapulu M; Biosciences Department, Kenya Medical Research Institute KEMRI-Wellcome Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kreidenweiss A; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany., Franke-Fayard B; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Agnandji ST; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon., López Mikue MA; Ministry of Health and Social Welfare, Government of Equatorial Guinea, Malabo, Equatorial Guinea., McCall MBB; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany.; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon., Steinhardt L; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Oneko M; Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya., Olotu A; Bagamoyo Research and Training Center, Ifakara Health Institute, Bagamoyo, Tanzania., Vaughan AM; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA., Kublin JG; Department of Global Health, University of Washington, Seattle, WA, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Murphy SC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Center for Emerging and Re-emerging Infectious Diseases and Department of Microbiology, University of Washington, Seattle, WA, USA., Jongo S; Bagamoyo Research and Training Center, Ifakara Health Institute, Bagamoyo, Tanzania., Tanner M; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Laurens MB; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Daubenberger C; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Silva JC; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA., Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Janse CJ; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands., Roestenberg M; Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Sauerwein RW; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Abdulla S; Bagamoyo Research and Training Center, Ifakara Health Institute, Bagamoyo, Tanzania., Dicko A; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Bamako, Mali., Kappe SHI; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA., Sim BKL; Sanaria Inc, Rockville, MD, USA., Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Kremsner PG; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon., Hoffman SL; Sanaria Inc, Rockville, MD, USA.

المصدر: Expert review of vaccines [Expert Rev Vaccines] 2023 Jan-Dec; Vol. 22 (1), pp. 964-1007. Date of Electronic Publication: 2023 Aug 11.

نوع المنشور: Journal Article; Review; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8395 (Electronic) Linking ISSN: 14760584 NLM ISO Abbreviation: Expert Rev Vaccines Subsets: MEDLINE

مواضيع طبية MeSH: Malaria Vaccines* , Malaria*/prevention & control , Malaria, Falciparum*/prevention & control, Pregnancy ; Child ; Animals ; Humans ; Female ; Sporozoites ; Translational Science, Biomedical ; Vaccines, Attenuated ; Plasmodium falciparum ; Immunization

المؤلفون: Morter R; Nuffield Department of Clinical Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Tiono AB; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Nébié I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Hague O; Nuffield Department of Clinical Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Viebig NK; European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Heidelberg, Germany., Hill AVS; Nuffield Department of Clinical Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Ewer KJ; Nuffield Department of Clinical Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.

المصدر: Frontiers in immunology [Front Immunol] 2022 Dec 02; Vol. 13, pp. 1058227. Date of Electronic Publication: 2022 Dec 02 (Print Publication: 2022).

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Malaria*/prevention & control , Malaria Vaccines*, Adult ; Child ; Humans ; Infant ; Burkina Faso ; Immunoglobulin G ; Kenya ; Vaccinia virus

SCR Organism: chimpanzee adenovirus serotype 63

المؤلفون: Kc N; Sanaria Inc., Rockville, MD, United States., Church LWP; Sanaria Inc., Rockville, MD, United States., Riyahi P; Sanaria Inc., Rockville, MD, United States., Chakravarty S; Sanaria Inc., Rockville, MD, United States., Seder RA; Vaccine Research Center, National Institute of Heath, Bethesda, MD, United States., Epstein JE; Naval Medical Research Center (NMRC), Silver Spring, MD, United States., Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States., Mordmüller B; Institut für Tropenmedizin, Eberhard Karls Universität Tübingen and German Center for Infection Research, Tübingen, Germany.; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Kremsner PG; Institut für Tropenmedizin, Eberhard Karls Universität Tübingen and German Center for Infection Research, Tübingen, Germany.; Centre de Recherches Medicales de Lambaréné, Lambaréné, Gabon., Sissoko MS; Malaria Research and Training Center (MRTC), Mali National Institute of Allergy and Infectious Diseases International Centers for Excellence in Research, University of Science, Techniques and Technologies of Bamako, Bamako, Mali., Healy S; Laboratory of Malaria Immunology and Parasitology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health (LMIV/NIAID/NIH), Rockville, MD, United States., Duffy PE; Laboratory of Malaria Immunology and Parasitology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health (LMIV/NIAID/NIH), Rockville, MD, United States., Jongo SA; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Nchama VUNN; Ministry of Health and Social Welfare, Malabo, Equatorial Guinea., Abdulla S; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Mpina M; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania.; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Sirima SB; Groupe de Recherche Action en Santé, Ouagadougou, Burkina Faso.; Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso., Laurens MB; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States., Steinhardt LC; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States., Oneko M; Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya., Li M; Sanaria Inc., Rockville, MD, United States., Murshedkar T; Sanaria Inc., Rockville, MD, United States., Billingsley PF; Sanaria Inc., Rockville, MD, United States., Sim BKL; Sanaria Inc., Rockville, MD, United States., Richie TL; Sanaria Inc., Rockville, MD, United States., Hoffman SL; Sanaria Inc., Rockville, MD, United States.

المصدر: Frontiers in immunology [Front Immunol] 2022 Oct 25; Vol. 13, pp. 1006716. Date of Electronic Publication: 2022 Oct 25 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Malaria Vaccines* , Malaria, Falciparum*/prevention & control , Malaria*/drug therapy, Adult ; Child ; Infant ; Animals ; Female ; Humans ; Male ; Plasmodium falciparum ; Sporozoites

المؤلفون: Hien D; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso. d.hien@gras.bf., Kaboré JMT; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Siribié M; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.; Internationnal Vaccine Institute (IVI), Seoul, Republic of Korea., Soulama I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Barry N; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Baguiya A; Institut de Recherche en Sciences de la Santé (IRSS), Ouagadougou, Burkina Faso., Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Tchouatieu AM; Medicines for Malaria Venture (MMV), Geneva, Switzerland., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.

المصدر: Malaria journal [Malar J] 2022 Jun 27; Vol. 21 (1), pp. 202. Date of Electronic Publication: 2022 Jun 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE

مواضيع طبية MeSH: Antimalarials*/therapeutic use , Artemisinins*/therapeutic use , Malaria*/drug therapy , Malaria, Falciparum*/drug therapy, Amodiaquine/therapeutic use ; Artemether/therapeutic use ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artesunate ; Burkina Faso ; Drug Combinations ; Drug Therapy, Combination ; Humans ; Naphthyridines